Creative Biolabs provides research-use epitope mapping and mimicking service to help scientists discover candidate peptide motifs, mimotopes, and binding patterns using phage display-based screening and structured follow-up planning. The service is designed for antibody characterization, antigen design, assay reagent development, vaccine-related research, and mechanism-oriented binding studies.
Phage display can enrich peptides that bind an antibody, serum fraction, receptor, or antigenic target. These hits may suggest linear motifs, mimetic surfaces, or regions worth further testing. Because selected peptides do not automatically prove the native epitope, we report findings with clear interpretation boundaries and recommend orthogonal confirmation when needed.
This service is useful when a research team has an antibody, serum sample, antigen, or receptor-binding question but lacks a clear map of the binding motif. It can also support projects where a mimotope is needed for assay design or candidate antigen exploration.
We design the screening route around the binding reagent, target format, library type, negative-selection need, panning stringency, and downstream confirmation plan. Depending on the project, the workflow can use random peptide libraries, constrained peptide libraries, antibody-guided selection, antigen-guided enrichment, competitive elution, or motif-clustering analysis.
Screen peptide libraries against monoclonal antibodies, polyclonal fractions, or selected binding reagents.
Recover peptide motifs that mimic part of an antigenic surface or binding determinant.
Use blocking or counter-selection to reduce nonspecific binders and matrix-driven enrichment.
Recommend follow-up assays such as competitive binding, alanine scanning, or mutagenesis.
Discuss Your Epitope Mapping Goal
We define whether the project seeks a linear motif, mimotope, or candidate binding pattern.
The antibody, antigen, serum fraction, or receptor format is assessed for screening suitability.
Random, constrained, or project-specific peptide libraries are selected.
Selection rounds are performed with controlled washing and elution strategy.
Recovered clones or pools are analyzed for enrichment and motif patterns.
We provide motif-level interpretation and confirmation suggestions.
| Input Type | Useful Details |
|---|---|
| Binding Reagent | Antibody, serum fraction, receptor, antigen, or purified protein, plus concentration and buffer if available. |
| Research Goal | Linear epitope search, mimotope discovery, cross-reactivity analysis, antigen design, or assay-reagent planning. |
| Confirmation Needs | Preferred follow-up assay, competitor peptide plan, mutagenesis interest, or structural-mapping context. |
Creative Biolabs can help select a practical screening route when the native epitope is unknown or difficult to present.
Ask About Antigen and Antibody Inputs
Library, panning conditions, selection notes, and control observations.
Recovered peptide or clone sequences, enrichment notes, and redundancy summary.
Candidate consensus motifs, clusters, and sequence-pattern comments.
Clear distinction between candidate mimotope evidence and confirmed native epitope mapping.
QC focuses on target presentation, reagent quality, nonspecific background, negative-control behavior, enrichment trend, sequence readability, clone redundancy, and repeatability of key signals. We avoid stating that a selected peptide is a definitive epitope unless follow-up evidence supports that conclusion.
Customization options include library type, peptide length, constrained versus linear display, target immobilization route, counter-selection target, elution strategy, sequencing depth, motif-clustering format, and follow-up confirmation plan. We can also coordinate related peptide synthesis or binding assay support when suitable.
Plan a Mimotope Discovery Study
A 2023 review in Vaccines summarized how phage display can support epitope and mimotope identification for infectious-pathogen vaccine research. The article describes the use of peptide display libraries to select binding motifs that resemble antigenic determinants recognized by antibodies or immune sera. It also discusses how selected mimotopes can help map antibody recognition patterns and guide candidate antigen design. This article highlights how phage display is useful for discovering candidate motifs, but those motifs require follow-up confirmation to establish biological meaning. Binding assays, competitive inhibition, alanine scanning, mutagenesis, structural mapping, or orthogonal biophysical assays may be needed depending on the research goal. This supports a cautious service boundary in which selected sequences are reported as candidate epitope or mimotope leads, not definitive proof of a native conformational epitope.
This published study is summarized as research background only. It does not represent proof of project performance or guarantee a client-specific result.
Fig.1 Workflow from epitope selection to phage-based vaccine production. 1
Q: What information is needed to start an epitope mapping project?
A: We usually need the antibody or binding reagent, antigen information if available, research goal, buffer and concentration details, and any preferred follow-up confirmation method.
Q: Can phage display identify conformational epitopes?
A: It can discover mimotopes that may mimic parts of a conformational epitope, but the native epitope usually requires orthogonal confirmation such as competition, mutagenesis, or structural mapping.
Q: Can you work with serum samples?
A: We can discuss serum-based or polyclonal projects case by case. Additional blocking, counter-selection, and interpretation controls may be needed because serum contains mixed binding populations.
Q: What deliverables are included?
A: We typically provide screening notes, enriched peptide or clone sequences, motif clustering, candidate ranking, and interpretation boundaries with follow-up confirmation suggestions.
Q: Can you help with peptide synthesis after screening?
A: Yes. Candidate peptides or mimotopes can be discussed for downstream synthesis and binding confirmation if the sequence quality and project goal support that step.
Q: How do you avoid overinterpreting mimotope results?
A: We report selected peptides as candidates and separate enrichment evidence from confirmed native epitope evidence. We recommend appropriate follow-up assays before stronger claims are made.
Reference:
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
